Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Colombo

Showing results (251-260 of 289) with videos related to

Pageof 29
Sort By:
BMC Pulmonary Medicine|December 23, 2018
Clinical expression of cystic fibrosis in a large cohort of Italian siblingsVito Terlizzi, Marco Lucarelli, Donatello Salvatore, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 23, 2009
Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian studyVincenzina Lucidi, Federico Alghisi, Valeria Raia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid CancerXiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2020
Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosisJoaquim Calvo-Lerma, Mieke Boon, Carla Colombo, et al.
Journal of Medical Genetics|October 15, 2016
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex allelesVito Terlizzi, Giuseppe Castaldo, Donatello Salvatore, et al.
International Journal of Systematic and Evolutionary Microbiology|August 9, 2016
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. novEnrico Tortoli, Thomas A Kohl, Barbara A Brown-Elliott, et al.
The New England Journal of Medicine|May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTRClaire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronateMaria Luisa Bianchi, Carla Colombo, Baroukh M Assael, et al.
Annals of the American Thoracic Society|March 16, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: Results from an open-label extension studyJames F Chmiel, Kimberly McBennett, Bradley S Quon, et al.
Plos One|March 23, 2019
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter studyDaniela Dolce, Stella Neri, Laura Grisotto, et al.
Pageof 29

Showing results (251-260 of 289) with videos related to

Sort By:
Pageof 29
BMC Pulmonary Medicine|December 23, 2018
Clinical expression of cystic fibrosis in a large cohort of Italian siblingsVito Terlizzi, Marco Lucarelli, Donatello Salvatore, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 23, 2009
Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian studyVincenzina Lucidi, Federico Alghisi, Valeria Raia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid CancerXiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2020
Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosisJoaquim Calvo-Lerma, Mieke Boon, Carla Colombo, et al.
Journal of Medical Genetics|October 15, 2016
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex allelesVito Terlizzi, Giuseppe Castaldo, Donatello Salvatore, et al.
International Journal of Systematic and Evolutionary Microbiology|August 9, 2016
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. novEnrico Tortoli, Thomas A Kohl, Barbara A Brown-Elliott, et al.
The New England Journal of Medicine|May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTRClaire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronateMaria Luisa Bianchi, Carla Colombo, Baroukh M Assael, et al.
Annals of the American Thoracic Society|March 16, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: Results from an open-label extension studyJames F Chmiel, Kimberly McBennett, Bradley S Quon, et al.
Plos One|March 23, 2019
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter studyDaniela Dolce, Stella Neri, Laura Grisotto, et al.
Pageof 29